ABSTRACT
Fact Sheet for Healthcare Providers: Diazyme Laboratories, Inc. Diazyme DZ-Lite SARS-CoV-2 IgG CLIA Kit [open pdf - 80KB]
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of Diazyme DZ-Lite SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] IgG [Immunoglobulin G] CLIA [Clinical Laboratory Improvement Amendments] Kit. The Diazyme DZ-Lite SARS-CoV-2 IgG CLIA Kit is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum or plasma (potassium EDTA [ethylenediaminetetraacetic acid], disodium EDTA and lithium heparin)."
| Publisher: | |
| Date: | 2020-07-08 |
| Series: | |
| Copyright: | Public Domain |
| Retrieved From: | U.S. Food and Drug Administration: https://www.fda.gov/ |
| Format: | pdf |
| Media Type: | application/pdf |
| URL: |